Cyclacel Pharmaceuticals Inc (CYCC) — Cash Flow-to-Debt Ratio
Cyclacel Pharmaceuticals Inc (CYCC) has a Cash Flow-to-Debt Ratio of -1.37x as of June 2025, meaning its operating cash flow of $-1.06K could theoretically repay -1% of its total liabilities ($770.00) in one year. Check Cyclacel Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cyclacel Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for Cyclacel Pharmaceuticals Inc across 22 annual periods. Also explore Cyclacel Pharmaceuticals Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Cyclacel Pharmaceuticals Inc (2003–2024)
Year-by-year debt coverage analysis for Cyclacel Pharmaceuticals Inc. For market capitalisation and broader financial context, see CYCC company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.27x | $-7.99 Million | $6.27 Million | ▲ +35.1% |
| 2023 | -1.97x | $-16.11 Million | $8.20 Million | ▲ +28.1% |
| 2022 | -2.73x | $-20.83 Million | $7.62 Million | ▲ +19.7% |
| 2021 | -3.41x | $-18.54 Million | $5.44 Million | ▼ -52.1% |
| 2020 | -2.24x | $-7.93 Million | $3.54 Million | ▲ +14.4% |
| 2019 | -2.62x | $-9.45 Million | $3.61 Million | ▼ -77.7% |
| 2018 | -1.47x | $-6.70 Million | $4.55 Million | ▲ +16.6% |
| 2017 | -1.77x | $-7.48 Million | $4.24 Million | ▲ +5.6% |
| 2016 | -1.87x | $-10.08 Million | $5.39 Million | ▲ +23.3% |
| 2015 | -2.44x | $-14.46 Million | $5.93 Million | ▼ -0.4% |
| 2014 | -2.43x | $-18.70 Million | $7.70 Million | ▼ -0.1% |
| 2013 | -2.43x | $-18.20 Million | $7.50 Million | ▼ -88.2% |
| 2012 | -1.29x | $-12.04 Million | $9.34 Million | ▲ +40.0% |
| 2011 | -2.15x | $-13.98 Million | $6.50 Million | ▲ +12.4% |
| 2010 | -2.46x | $-16.04 Million | $6.54 Million | ▼ -58.7% |
| 2009 | -1.55x | $-15.19 Million | $9.82 Million | ▲ +46.6% |
| 2008 | -2.90x | $-29.91 Million | $10.31 Million | ▼ -124.8% |
| 2007 | -1.29x | $-23.14 Million | $17.94 Million | ▲ +40.2% |
| 2006 | -2.16x | $-20.17 Million | $9.36 Million | ▲ +31.4% |
| 2005 | -3.14x | $-21.51 Million | $6.84 Million | ▼ -71.2% |
| 2004 | -1.84x | $-21.09 Million | $11.48 Million | ▼ -888.2% |
| 2003 | -0.19x | $-15.49 Million | $83.34 Million | — |